By Christiana Sciaudone
Investing.com -- Opko Health (NASDAQ:OPK) Inc. and Owens & Minor Inc . both traded higher Tuesday on coronavirus-related news.
Opko rose 24% after its BioReference Laboratories was chosen for Covid-19 testing for the National Football League, CNBC’s Jim Cramer reported. Tests will take place for all 32 teams in 30 cities.
BioReference previously said it would provide testing for the National Basketball Association and Major League Soccer. Football players will be tested for Covid-19 twice before entering club facilities.
Healthcare services provider Owens & Minor Inc (NYSE:OMI) rose 81% after announcing preliminary results for the second quarter that benefited from a boost in demand for personal protective equipment, as well as an earlier-than-expected increase in elective procedures, a favorable product mix and operating efficiencies.
Owens & Minor expects to report net income (loss) per share from continuing operations for the second quarter of 2020 to be in a range of ($0.02) to $0.00 and adjusted net income per share to be in a range of $0.18 to $0.20.
The company also revised its outlook for full-year adjusted net income from $0.50 to $0.60 per share on a constant currency basis to adjusted net income of $1.00 to $1.20 per share. Owens & Minor reports earnings on August 4.